3rd Quarter - Report

DAIICHI SANKYO, INC. for DAIICHI SANKYO INC

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions regarding the Affordable Care Act (ACA) Discussions regarding Drug sales information reporting (DSIR) Discussions regarding Food Drug & Cosmetic Act Discussions regarding 340B Drug Program Discussions regarding generic drug pricing

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
LANCE GILGORE —

Contacted: HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Discussions regarding Medicare and Medicaid

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
LANCE GILGORE —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.